Progesterone, androgen and estrogen receptor agonists/antagonists
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
G GENITO URINARY SYSTEM AND SEX HORMONES
G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
G03X OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
G03XB Progesterone receptor modulators
G03XB01 Mifepristone
D00585 Mifepristone (JAN/USAN/INN) <US>
USP drug classification [BR:br08302]
Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers), Other
Mifepristone
D00585 Mifepristone (JAN/USAN/INN)
Drug groups [BR:br08330]
Hormonal agent
DG01667 Progesterone receptor antagonist
D00585 Mifepristone
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D00585 Mifepristone
Metabolizing enzyme inhibitor
DG02852 CYP3A/CYP3A4 inhibitor
D00585 Mifepristone
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
3-Ketosteroid receptor
NR3C1 (GR)
D00585 Mifepristone (JAN/USAN/INN) <US>
NR3C3 (PGR)
D00585 Mifepristone (JAN/USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D00585
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D00585
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D00585